{"id":"https://openalex.org/W2597274344","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.599","title":"Impact of hormone receptor (HR) status on clinicopathological features, patterns of recurrence, and clinical outcomes among patients (pts) with human epidermal growth factor receptor-2 positive (HER2) breast cancer (BC) in the National Comprehensive Cancer Network (NCCN).","display_name":"Impact of hormone receptor (HR) status on clinicopathological features, patterns of recurrence, and clinical outcomes among patients (pts) with human epidermal growth factor receptor-2 positive (HER2) breast cancer (BC) in the National Comprehensive Cancer Network (NCCN).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2597274344","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.599","mag":"2597274344"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.599","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.599","is_oa":false,"landing_page_url":"http://doi.org/10.1200/jco.2012.30.15_suppl.599","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103783700","display_name":"In\u00eas Maria Vaz Duarte Luis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ines Maria Vaz Duarte Luis","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053598597","display_name":"Rebecca A. Ottesen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca A Ottesen","raw_affiliation_strings":["City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015055171","display_name":"Melissa E. Hughes","orcid":"https://orcid.org/0000-0001-6190-9101","observed_orcids":["https://orcid.org/0000-0001-6190-9101"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa E Hughes","raw_affiliation_strings":["Dana-Farber Cancer Institute, Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Lexington, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005726073","display_name":"Paul Kelly Marcom","orcid":"https://orcid.org/0000-0001-5302-6368","observed_orcids":["https://orcid.org/0000-0001-5302-6368"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Kelly Marcom","raw_affiliation_strings":["Duke University Medical Center, Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, NC","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017550097","display_name":"Beverly Moy","orcid":"https://orcid.org/0000-0003-3472-1140","observed_orcids":["https://orcid.org/0000-0003-3472-1140"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Moy","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":["University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010686398","display_name":"Richard L. Theriault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard L. Theriault","raw_affiliation_strings":["University of Texas M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065991918","display_name":"John L. Wilson","orcid":"https://orcid.org/0000-0002-9317-5525","observed_orcids":["https://orcid.org/0000-0002-9317-5525"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Wilson","raw_affiliation_strings":["Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071631687","display_name":"Joyce C. Niland","orcid":"https://orcid.org/0000-0002-3001-517X","observed_orcids":["https://orcid.org/0000-0002-3001-517X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce C. Niland","raw_affiliation_strings":["City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109241973","display_name":"Jane C. Weeks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jane C. Weeks","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy U. Lin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"15_suppl","first_page":"599","last_page":"599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0414000004529953,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.996999979019165},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.7409999966621399},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":1.0},{"id":"https://openalex.org/keywords/cns-relapse","display_name":"central nervous system relapse","score":0.7670000195503235},{"id":"https://openalex.org/keywords/lung-recurrence","display_name":"lung recurrence","score":0.6209999918937683},{"id":"https://openalex.org/keywords/bone-recurrence","display_name":"bone recurrence","score":0.5860000252723694},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8610000014305115},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.5849999785423279},{"id":"https://openalex.org/keywords/clinicopathological-features","display_name":"clinicopathological features","score":0.656000018119812},{"id":"https://openalex.org/keywords/nccn-guidelines","display_name":"NCCN guidelines","score":0.4350000023841858},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.3149999976158142},{"id":"https://openalex.org/keywords/postmenopausal-patients","display_name":"postmenopausal patients","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9405454993247986},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7099584937095642},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6094245314598083},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5197679400444031},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.5086966156959534},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4904577434062958},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48711466789245605},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.4575689136981964},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4430536925792694},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39268064498901367},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2767691910266876},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.17556926608085632}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.599","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.599","is_oa":false,"landing_page_url":"http://doi.org/10.1200/jco.2012.30.15_suppl.599","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2108863890","https://openalex.org/W2793904107","https://openalex.org/W4391727361","https://openalex.org/W4402965503","https://openalex.org/W3010301908","https://openalex.org/W2099014119","https://openalex.org/W2944179832","https://openalex.org/W2966196357","https://openalex.org/W4306316545","https://openalex.org/W7162638016"],"abstract_inverted_index":{"599":[0],"Background:":[1],"According":[2],"to":[3,13,25,86,90,122,142,184],"gene":[4],"expression":[5],"profiling,":[6],"HER2+":[7,31,286,298],"BC":[8,32,82,214,287,299],"is":[9,300],"heterogeneous":[10],"and":[11,43,46,54,74,89,95,139,166,206,279,312],"appears":[12],"diverge":[14],"by":[15,289],"HR":[16,290,295],"status.":[17,291],"Methods:":[18],"We":[19],"evaluated":[20],"3394":[21],"pts":[22,101,218],"who":[23],"presented":[24],"NCCN":[26],"centers":[27],"with":[28,80,92,240],"stage":[29,94],"I-III":[30],"between":[33],"2000-07.":[34],"Pts":[35,79],"were":[36,59,83,112,119,162,181],"classified":[37],"as":[38],"HR+":[39,73,217],"(ER+":[40],"and/or":[41],"PR+)":[42],"HR-":[44,76,81,117,180,208,241],"(ER-":[45],"PR-).":[47],"Chi-square,":[48],"univariate":[49],"logistic":[50],"regression,":[51],"log-rank":[52],"test,":[53],"Cox":[55],"hazard":[56,245],"proportional":[57,237],"regression":[58],"used":[60],"for":[61,114,198,285],"analysis.":[62],"Results:":[63],"Median":[64],"follow-up":[65],"was":[66,176,235],"51":[67],"months.":[68],"59%":[69],"of":[70,157,169,201,221,233,277,281],"patients":[71,118],"had":[72,209],"41%":[75],"disease":[77,98],"respectively.":[78],"more":[84,120,182],"likely":[85,121,141,183],"be":[87,306],"postmenopausal":[88],"present":[91],"higher":[93],"high":[96],"grade":[97],"(p<0.001).":[99],"Most":[100],"received":[102,108],"adjuvant":[103,109],"or":[104,159],"neoadjuvant":[105],"therapy;":[106],"44%":[107],"trastuzumab.":[110],"Recurrences":[111],"recorded":[113],"458":[115],"pts.":[116],"recur":[123,143],"first":[124,165,248],"in":[125,144,155,173,246,297],"the":[126,171,231,247],"central":[127],"nervous":[128],"system":[129],"(CNS)":[130],"(OR:":[131,146,188],"1.8,":[132],"95%":[133,148,190,225],"CI:":[134,149,191,226],"1.1,":[135],"2.9;":[136],"p=":[137,194],"0.03)":[138],"less":[140],"bone":[145],"0.5,":[147],"0.3,":[150],"0.8;":[151],"p<0.01).":[152,229],"No":[153],"differences":[154,304],"risk":[156,232,280],"lung":[158,186],"liver":[160],"recurrence":[161],"observed.":[163],"Combining":[164],"subsequent":[167],"sites":[168,276],"recurrence,":[170,278],"difference":[172],"CNS":[174],"involvement":[175,187],"lost":[177],"(p=0.107)":[178],"but":[179],"experience":[185],"1.5,":[189,261],"1.0,":[192],"2.2;":[193],"0.05).":[195],"After":[196],"adjusting":[197],"age,":[199],"year":[200],"diagnosis":[202,215],"(y),":[203],"race,":[204],"stage,":[205],"grade,":[207],"worse":[210],"survival":[211],"after":[212],"initial":[213],"than":[216],"(Hazard":[219],"Ratio":[220],"death":[222,234,282],"[HRd]":[223],"1.4,":[224],"1.14,":[227],"1.7;":[228],"However,":[230],"not":[236],"over":[238,283],"time":[239,284],"having":[242],"significantly":[243],"increased":[244],"five":[249],"years:":[250],"HRd":[251,259,265],"0-2":[252],"y":[253],"1.9":[254],"[1.3,":[255],"2.9];":[256],"p<":[257],"0.01;":[258],"2-5y":[260],"[1.2,":[262],"2.0];":[263],"p<0.01;":[264],"5+":[266],"y,":[267],"0.8,":[268],"[":[269],"0.6,":[270],"1.2],":[271],"p=0.29.":[272],"Conclusions:":[273],"Clinicopathological":[274],"features,":[275],"differed":[288],"This":[292],"suggests":[293],"that":[294],"status":[296],"clinically":[301],"relevant.":[302],"These":[303],"should":[305],"further":[307],"explored":[308],"from":[309],"a":[310],"mechanistic":[311],"therapeutic":[313],"standpoint.":[314]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-03-23T00:00:00"}